Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes
申请人:APOGLYX AB
公开号:US10011597B2
公开(公告)日:2018-07-03
Disclosed are compounds, pharmaceutical compositions and methods for modulating aquaporin 9.
所公开的是调节水蒸气素 9 的化合物、药物组合物和方法。